Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-11 Sale |
2023-08-11 4:10 pm |
Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO |
1,925 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-27 Option Award |
2024-11-27 5:10 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-05-01 4:27 pm |
N/A 2034-04-29 |
ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-01 4:46 pm |
N/A 2033-02-27 |
Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO |
165,000 | $0 | 165,000 (Direct) |
View |
Ownership |
2023-03-01 4:35 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO |
0 | $0 | 343,570 (Direct) |
View |